Bis­[2‐(di­phenyl­phosphinoyl)­benzene] di­sulfide

The title compound, [2‐Ph₂P(O)C₆H₄S]₂ or C₃₆H₂₈O₂P₂S₂, obtained by electrochemical oxidation of 2‐(di­phenyl­phosphino)­benzene­thiol, has twofold crystallographic symmetry. Principal dimensions include S—S 2.0212 (15) Å, S—C 1.786 (3) Å and C—S—S—C 81.34 (14)°.     

Di­aza­bi­cyclo­[2.2.2]­octane‐1,4‐diium dichromate

The title compound, (C₆H₁₄N₂)[Cr₂O₇], consists of a di­aza­bi­cyclo­[2.2.2]­octane‐1,4‐diium cation and a discrete dichromate anion, which are linked in the crystal by N—H⋯O hydrogen bonds. The cation is ordered and distorted, owing to the confinement and twist of the hydrogen bonds involved. Two CrO₄ tetrahedra are joined through a shared O atom to form the dichromate anion. Chiral supramolecular chains of the title compound are built up via N—H⋯O hydrogen bonds, and C—H⋯O interactions play subordinate roles in forming the structure.     

1,4‐Di­aza­bi­cyclo­[2.2.2]­octane‐1,4‐diium trichromate

The title compound, (C₆H₁₄N₂)[Cr₃O₁₀], consists of a di­aza­bi­cyclo­[2.2.2]­octane‐1,4‐diium cation and a discrete trichromate anion linked by an N—H⋯O hydrogen bond. Three CrO₄ tetrahedra are joined via shared O atoms to form the trichromate anion. Supramolecular rings, which can be described by the graph‐set motif (26), are built via N—H⋯O hydrogen bonds, and C—H⋯O interactions play lesser roles in forming the structure.     

Benzo­[i]­naphtho­[c,d]­bi­cyclo­[5.4.1]dodecan‐12‐one

In the title compound, penta­cyclo­[11.8.1.1^3,11.0^7,23.0^15,20]­tricosa‐3,5,7,9,11(23),15,17,19‐octaen‐22‐one, C₂₃H₂₀O, the bi­cyclo­[5.4.1]­dodecan‐12‐one moiety takes a rigid conformation in which the seven‐ and eight‐membered rings take chair and boat–boat forms, respectively. The mol­ecule has a non‐crystallographic mirror symmetry perpendicular to the benzene and naphthalene planes.     

2‐(1,3‐Dithian‐2‐yl)benzaldehyde and N‐{2‐[2‐(1,3‐dioxan‐2‐yl)phenoxy]­ethyl}phthalimide

The crystal structures of two elaborated‐porphyrin precursors have been determined. In the crystalline state, 2‐(1,3‐di­thian‐2‐yl)­benz­aldehyde, C₁₁H₁₂OS₂, has its di­thiane ring in a slightly distorted chair conformation. The mol­ecules pack in anti‐parallel chains. N‐{2‐[2‐(1,3‐Dioxan‐2‐yl)­phenoxy]­ethyl}­phthal­imide, C₂₀H₁₉NO₅, is in a folded conformation. The dihedral angle between the phthal­imide and phenyl planes is 80.07 (3)°. In the crystalline states, mol­ecules stack on top of one another.     

()‐5‐(4‐Methoxy­phenyl­amino­carbonyl)‐1‐aza­bi­cyclo­[3.3.0]octan‐2‐one benzene solvate

The title trans prolyl amide exists as a benzene solvate, C₁₅H₁₈N₂O₃·C₆H₆, with positional disorder of the prolyl ring. The molecular structure is influenced by a close intramolecular N—H⋯N contact that provides structural support for the intramolecular catalysis of peptidyl–prolyl cis–trans isomerization.     

2‐[3‐Furyl­(hydroxy)­methyl]‐2,3‐di­methyl­cyclo­hexanone

In the mol­ecule of the title compound, C₁₃H₁₈O₃, there is a syn relationship between the two vicinal methyl groups. The six‐membered ring adopts a chair conformation, with one equatorial and two axial groups, and the furyl group is almost parallel to the ketone group. Intermolecular hydrogen bonds [O—H?O=C 2.814 (3) Å] form chains along [100].     

Bis{μ‐2‐[3‐(cyclo­hexyl­ammonio)­propyl­imino­methyl]­phenolato}bis­[di­chloro­copper(II)]

The title compound, [Cu₂(C₁₆H₂₄N₂O)₂Cl₄], is a dinuclear copper(II) complex with inversion symmetry. Each Cu^II atom is five‐coordinated by two O and one N atom from two Schiff base ligands, and by two Cl atoms, giving an approximately trigonal–bipyramidal coordination environment.     

Ethyl N‐[2‐(hydroxy­acetyl)­phenyl]­carbamate,ethyl N‐[2‐(hydroxy­acetyl)‐4‐iodo­phenyl]­carbamate and ethyl N‐[2‐(hydroxy­acetyl)‐4‐methyl­phenyl]­carbamate

In ethyl N‐[2‐(hydroxy­acetyl)phenyl]carbamate, C₁₁H₁₃NO₄, all of the non‐H atoms lie on a mirror plane in the space group Pnma; the mol­ecules are linked into simple chains by a single C—H⋯O hydrogen bond. The mol­ecules of ethyl N‐[2‐(hydroxy­acetyl)‐4‐iodo­phenyl]carbamate, C₁₁H₁₂INO₄, are linked into sheets by a combination of O—H⋯I and C—H⋯O hydrogen bonds and a dipolar I⋯O contact. Ethyl N‐­[2‐(hydroxy­acetyl)‐4‐methyl­phenyl]carbamate, C₁₂H₁₅NO₄, crystallizes with Z′ = 2 in the space group P; pairs of mol­ecules are weakly linked by an O—H⋯O hydrogen bond and these aggregates are linked into chains by two independent aromatic π–π stacking inter­actions.     

Bis­[μ‐2‐(1,4,7,10‐tetraoxa‐13‐aza­cyclo­pentadeca‐13‐yl)­cyclo­hepta‐2,4,6‐trien‐1‐one]­bis­[bis­(thio­cyanato)­barium(II)]

In the title complex, [Ba₂(NCS)₄(C₁₇H₂₅NO₅)₂], each Ba²⁺ cation is coordinated by one N atom, four O atoms of the macrocyclic unit, two N atoms of thio­cyanate unit and one O atom from each of the tropone units.     

1‐{5‐[2‐(Tri­fluoro­methyl)­phenyl]‐1,3,4‐thia­diazol‐2‐yl}guanidinium chloride

In the title compound, C₁₀H₉F₃N₅S⁺·Cl^?, which was developed as a potential anticonvulsant, the phenyl ring, the thia­diazo­le ring and the guanidinium moiety are all planar. There is a dihedral angle of 48.9 (1)° between the thia­diazole and phenyl rings which prevents steric hindrance arising from the π bonds within the former, and the tri­fluoro­phenyl moiety attached to the latter. The thia­diazole and guanidinium moieties are twisted by 12.7 (2)° with respect to each other. An extensive network of hydrogen bonds, predominantly involving the chloride ion, maintains the crystal structure.     

Tris­[2‐(2‐oxazolin‐2‐yl)­phenolato]­iron(III)

The title compound, tris­[2‐(4,5‐dihydrooxazol‐2‐yl‐κN)phenolato‐κO]­iron(III), [Fe(C₉H₈NO₂)₃], is disordered over a non‐crystallographic twofold rotation axis perpendicular to the crystallographic threefold rotation axis. The disorder can be a pure rotational disorder of an iron complex in the facial configuration, or the consequence of a mixture of facial and meridional configurations. In the latter case, at least 25% of the iron complexes must adopt the facial configuration in order to obtain the disorder ratio observed in the crystal.     

Tri­benzyl{η5‐[2‐(p‐tolyl)­prop‐2‐yl]­cyclo­penta­dienyl}­zirconium

The title compound, [Zr(C₇H₇)₃(C₁₅H₁₇)], (I), crystallizes from light petroleum with two independent mol­ecules in the asymmetric unit. Whereas in the parent mol­ecule, Zr(η⁵‐C₅H₅)(CH₂Ph)₃, all three Zr—CH₂Ph angles are equal, in (I), they differ significantly. In spite of their different environments, both independent mol­ecules in (I) exhibit a small, an expected, and a large Zr—CH₂Ph angle. The angles are similar to those of the closely related tri­benzyl­[η⁵‐(benzyl­di­methyl­silyl)­cyclo­penta­dienyl]­zirconium complex. The smallest Zr—CH₂Ph angle and the consequently relatively short Zr?C_ipso distance are indicative of η²‐bonding of the benzyl group.     

2‐[2‐(Pyrrolidin‐2‐yl)propan‐2‐yl]‐1H‐pyrrole and its amide derivative 1‐{2‐[2‐(1H‐pyrrol‐2‐yl)propan‐2‐yl]pyrrolidin‐1‐yl}ethanone

In the title compounds, C₁₁H₁₈N₂, (II), and C₁₃H₂₀N₂O, (III), the pyrrolidine rings have twist conformations. Compound (II) crystallizes with two independent molecules (A and B) in the asymmetric unit. The mean planes of the pyrrole and pyrrolidine rings are inclined to one another by 89.99 (11) and 89.35 (10)° in molecules A and B, respectively. In (III), the amide derivative of (II), the same dihedral angle is much smaller, at only 13.42 (10)°. In the crystal structure of (II), the individual molecules are linked via N—H...N hydrogen bonds to form inversion dimers, each with an R²₂(12) graph‐set motif. In the crystal structure of (III), the molecules are linked via N—H...O hydrogen bonds to form inversion dimers with an R²₂(16) graph‐set motif.     

Ethyl β‐{2‐[4‐(dimethylamino)phenyliminomethyl]‐1‐(phenylsulfonyl)indol‐3‐yl}acrylate

The title compound, C₂₈H₂₇N₃O₄S, crystallizes in the centrosymmetric space group P2₁/n, with one mol­ecule in the asymmetric unit. In the indole ring, the dihedral angle between the fused rings is 3.6 (1)°. The phenyl ring of the sulfonyl substituent makes a dihedral angle of 79.2 (1)° with the best plane of the indole moiety. The phenyl ring of the di­methyl­amino­phenyl group is orthogonal to the phenyl ring of the phenyl­sulfonyl group. The dihedral angle formed by the weighted least‐squares planes through the pyrrole ring and the phenyl ring of the di­methyl­amino­phenyl group is 7.8 (1)°. The molecular structure is stabilized by C—H?O and C—H?N interactions.     

Dichloro­{2‐[2‐(dimethyl­ammonio)­ethyl­imino­meth­yl]‐4‐nitro­phenolato}­zinc(II) in unsolvated and hemihydrate forms

The two title complexes, [ZnCl₂(C₁₁H₁₅N₃O₃)], (I), and [ZnCl₂(C₁₁H₁₅N₃O₃)]·0.5H₂O, (II), are mononuclear zinc(II) compounds. In both structures, the Zn^II atom is four‐coordinated in a tetra­hedral configuration by one imine N atom and one phenolate O atom of a Schiff base, and by two Cl atoms. The structure of each of the two zinc(II) complex molecules of (II) is similar to that of (I). In (I), the mol­ecules are linked through inter­molecular hydrogen bonds, forming a three‐dimensional framework. In (II), the solvent water mol­ecules are linked to the zinc(II) moieties through inter­molecular O—H⋯O and O—H⋯Cl hydrogen bonds. The mol­ecules in (II) are further linked via other inter­molecular hydrogen bonds, forming a three‐dimensional framework.     

1‐(2‐{4‐[6‐Hydro­xy‐2‐(4‐hydroxy­phenyl)­benzo­[b]­thiol‐3‐yl­carbonyl]­phenoxy}ethyl)­piperidinium chloride

The title compound, raloxifene hydro­chloride, C₂₈H₂₈NO₄S⁺·Cl^?, belongs to the benzo­thio­phene class of antiosteoporotic drugs. In the molecular cation, the 2‐phenol ring sustains a dihedral angle of 45.3 (1)° relative to the benzo­[b]­thio­phene system. The benzo­[b]­thio­phene and phenyl ring planes are twisted with respect to the carbonyl plane, with the smallest twist component occurring between the phenyl and carbonyl planes. The N atom bears the positive charge in the molecular cation and the piperidine ring adopts an almost perfect chair conformation. The Cl^? anion is involved in the formation of N—H?Cl and O—H?Cl intermolecular hydrogen bonds, which lead to the formation of a layer of molecular cations.     

3,3,10,10‐Tetra­methyl‐1,2‐di­thia‐5,8‐di­aza­cyclo­deca‐4,8‐diene

The title compound, C₁₀H₁₈N₂S₂, acts as an important precursor for the synthesis of the pharmaceutically important di­amine­di­thiol ligand system. The mol­ecule has a local twofold axis and the arrangement of the S₂N₂ donor atoms in the macrocycle is anticlinal.     

tert‐Butyl N‐{2‐[N‐(N,N′‐dicyclohexyl­ureido­carbonyl­ethyl)­carbamoyl]prop‐2‐yl}carbamate

The title compound, C₂₅H₄₄N₄O₅, exhibits a turn with the main chain reversing direction, held together by an intramol­ecular N—H?O hydrogen bond. In the urea fragment, a notable amide C—N bond between the carboxyl C and the tertiary N atom shows marked single‐bond character [1.437 (2) Å]. The dihedral angle of the β‐alanyl residue, centrally located in the turn, is gauche [69.2 (2)°]. The packing is mediated by two intermolecular hydrogen bonds and van der Waals contacts involving the methyl moieties and the cyclo­hexyl rings.     

[2,13‐Bis­(acet­amido)‐5,16‐di­methyl‐2,6,13,17‐tetra­aza­tri­cyclo­[16.4.0.07,12]­do­cosane]copper(II) dichloride octahydrate

The title compound, [Cu(C₂₄H₄₆N₆O₂)]Cl₂·8H₂O, contains a centrosymmetric cation, with the anions and water mol­ecules on general sites. The coordination geometry around the Cu^II ion is an axially elongated octahedron, with Cu—N distances of 2.0448 (17) and 2.0847 (17) Å, and a Cu—O1 distance of 2.3138 (16) Å.